Breelyn A. Wilky, MD (she/her/hers)
Associate Professor
University of Colorado Cancer Center
Aurora, Colorado, United States
Jonathan Trent, MD, PhD
Professor of Medicine
Sylvester Comprehensive Cancer Center, University of Miami
Miami, Florida, United States
Michael S. Gordon, MD
HonorHealth Research Institute
Scottsdale, Arizona, United States
Anthony B. El-Khoueiry, MD
University of Southern California Norris Comprehensive Cancer Center
Los Angeles, California, United States
Andrea J. Bullock, MD
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Brian S. Henick, MD
Interim Director, Experimental Therapeutics
Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine
New York, New York, United States
Gary K. Schwartz, MD
Professor
Herbert Irving Comprehensive Cancer Center at Columbia University School of Medicine
New York, New York, United States
Mark Agulnik, MD (he/him/his)
Sarcoma Section Chief
City of Hope, Department of Medical Oncology & Therapeutics Research
Duarte, California, United States
Daruka Mahadevan, MD, PhD (he/him/his)
Division Chief Hematology/Oncology
UT Health San Antonio
San Antonio, Texas, United States
Jaymin M. Patel, MD
Agenus Inc.
Lexington, Massachusetts, United States
Joseph E. Grossman, MD (he/him/his)
VP Early Stage Clinical Development
Agenus Inc.
Lexington, Massachusetts, United States
Katherine Rosenthal, RN, MSN, OCN, CCRP
Agenus Inc.
Lexington, Massachusetts, United States
Steven J. O’Day, MD (he/him/his)
Chief Medical Officer
Agenus Inc.
Lexington, Massachusetts, United States
Apostolia M. Tsimberidou, MD, PhD
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
